The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.
Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...
According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...
Good news is, Medicare does cover necessary cataract surgery including the removal of the cataract and the addition of a ...